This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Natco Pharma Limited. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Innovations of Shankar Reddy Budideti
Introduction
Shankar Reddy Budideti is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important compounds. With a total of two patents to his name, Budideti has demonstrated his expertise and commitment to innovation.
Latest Patents
Budideti's latest patents include a process for the preparation of N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin-4-amine dihydrochloride. This invention relates to an improved method for synthesizing this compound, which is crucial for various applications. Additionally, he has developed a process for the preparation of Ibrutinib, which is characterized by high purity and yield. This cost-effective process is also feasible for large-scale production and avoids the use of mitsunobu reagent conditions. Furthermore, his invention includes methods for preparing crystalline forms A and C of Ibrutinib.
Career Highlights
Shankar Reddy Budideti is currently associated with Natco Pharma Limited, where he applies his innovative skills to advance pharmaceutical research and development. His work has contributed to the company's reputation for producing high-quality pharmaceutical products.
Collaborations
Budideti has collaborated with notable colleagues such as Pulla Reddy Muddasani and Venkaiah Chowdary Nannapaneni. These collaborations have fostered a productive environment for innovation and development within the company.
Conclusion
Shankar Reddy Budideti is a distinguished inventor whose contributions to pharmaceutical processes have made a significant impact. His innovative approaches to compound preparation continue to advance the field and enhance the capabilities of Natco Pharma Limited.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
